Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas

Akyerli, Cemaliye B.; Yuksel, Sirin; Can, Ozge; Erson\\-Omay, E. Zeynep; Oktay, Yavuz; Cosgun, Erdal; Ulgen, Ege; Erdemgil, Yigit; Sav, Aydin; von Deimling, Andreas; Gunel, Murat; Yakicier, M. Cengiz; Pamir, M. Necmettin; Ozduman, Koray

doi:10.3171/2016.11.JNS16973

Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas

Date

2018

Authors

Akyerli, Cemaliye B.

Yuksel, Sirin

Can, Ozge

Erson\\-Omay, E. Zeynep

von Deimling, Andreas

dc.identifier.doi

10.3171/2016.11.JNS16973

dc.identifier.other

WOS:000429045500251

Publisher

AMER ASSOC NEUROLOGICAL SURGEONS

DOI

10.3171/2016.11.JNS16973

Keywords

glioma , isocitrate dehydrogenase , telomerase , mutation , prognosis , oncology

URI

https://openaccess.acibadem.edu.tr/handle/11443/8296

Collections

WOS

Full item page

Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas

Date

Authors

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

dc.identifier.other

dc.description.volume

dc.description.issue

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By